Can Allosteric Receptor-Protein Interactions in Receptor Complexes Be a Molecular Mechanism Involved in Cancer Immune
Dasiel O Borroto-Escuela1,2,3, Kjell Fuxe1
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Based on the work in the Central Nervous System with discoveries of allosteric receptor-receptor interactions in homo- and heteroreceptor complexes representing a major integrative mechanism in synapses and extrasynaptic regions, it is proposed that a similar mechanism may exist in the immunological synapses. We discuss a putative additional molecular mechanism for the ability of the inhibitory T cell signaling proteins CTLA-4 and PD-1 and the adenosine A2AR to diminish T cell activation leading to enhancement of cancer development. We suggest that in the same immunological synapse involving T cells and antigen presenting cells multiple heteroreceptor complexes may participate and be in balance with each other. Their composition can vary between functional states and among different types of T cells. The T cell receptor (TCR) and its accelerators, strongly enhancing T cell activation, can be under inhibitory control by T cell signaling proteins CTLA4 and PD-1 and also the adenosine A2AR through inhibitory allosteric receptor-receptor interactions in different types of heteroreceptor complexes. As a result, inhibitory tumor induced immunosuppression can develop due to a dominance of the inhibitory signaling causing a brake on the TCR and/or its accelerator and the cancer immunotherapy becomes blocked.
Insights
A novel allosteric mechanism involving receptor-receptor interactions in immune cells may explain how cancer evades the immune system. This interaction involving CTLA-4, PD-1, and adenosine A2AR can inhibit T cell activation, blocking cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Neuroscience
Background:
- Allosteric receptor-receptor interactions are key in the central nervous system.
- These interactions regulate synaptic and extrasynaptic signaling.
- Their role in immunological synapses is not well understood.
Purpose of the Study:
- To propose a similar allosteric receptor-receptor interaction mechanism in immunological synapses.
- To investigate the role of CTLA-4, PD-1, and adenosine A2AR in T cell inhibition and cancer development.
- To understand how these interactions impact T cell receptor (TCR) signaling and cancer immunotherapy.
Main Methods:
- Theoretical discussion based on existing literature and discoveries in neuroscience.
- Analysis of potential molecular mechanisms in T cell signaling.
- Hypothesizing the formation and function of heteroreceptor complexes in immunological synapses.
Main Results:
- A proposed mechanism where CTLA-4, PD-1, and adenosine A2AR form heteroreceptor complexes within the immunological synapse.
- These complexes can exert inhibitory control over T cell activation by interacting with the T cell receptor (TCR) and its accelerators.
- Imbalance in these complexes, favoring inhibitory signals, can lead to tumor-induced immunosuppression.
Conclusions:
- Allosteric receptor-receptor interactions represent a significant regulatory mechanism in immunological synapses.
- This mechanism provides a molecular basis for how tumors induce immunosuppression and resist immunotherapy.
- Targeting these inhibitory complexes could offer new strategies for enhancing cancer immunotherapy.
Related Concept Videos
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
16:16Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
06:01Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
G-protein Coupled Receptors
11:07Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding


